Literature DB >> 33827573

Spoligotype-specific risk of finding lesions in tissues from cattle infected by Mycobacterium bovis.

Alberto Gomez-Buendia1, Beatriz Romero1, Javier Bezos1,2, Francisco Lozano1, Lucía de Juan1,2, Julio Alvarez3,4.   

Abstract

BACKGROUND: Although the pathogenic effect of members of the Mycobacterium tuberculosis complex in susceptible hosts is well known, differences in clinical signs and pathological findings observed in infected animals have been reported, likely due to a combination of host and pathogen-related factors. Here, we investigated whether Mycobacterium bovis strains belonging to different spoligotypes were associated with a higher risk of occurrence of visible/more severe lesions in target organs (lungs and/or lymph nodes) from infected animals. A large collection of 8889 samples belonging to cattle were classified depending on the presence/absence of tuberculosis-like lesions and its degree of severity. All samples were subjected to culture irrespective of the presence of lesions, and isolates retrieved were identified and subjected to spoligotyping. The association between the presence/severity of the lesions and the isolation of strains from a given spoligotype was assessed using non-parametric tests and Bayesian mixed multivariable logistic regression models that accounted for origin (region and herd) effects.
RESULTS: Results suggested a difference in severity in lesioned samples depending on the strain's spoligotype. An association between specific spoligotypes and presence of lesions was observed, with a higher risk of finding lesions in animals infected with strains with spoligotypes SB0120, SB0295 and SB1142 compared with SB0121, and in those coming from certain regions in Spain.
CONCLUSIONS: Our results suggest that strains belonging to certain spoligotypes may be associated with a higher probability in the occurrence of gross/macroscopic lesions in infected cattle, although these observational findings should be confirmed in further studies that allow accounting for the effect of other possible confounders not considered here, and ultimately through experimental studies.

Entities:  

Keywords:  Animal tuberculosis; Lesion; Mycobacterium bovis; Spoligotype

Year:  2021        PMID: 33827573     DOI: 10.1186/s12917-021-02848-3

Source DB:  PubMed          Journal:  BMC Vet Res        ISSN: 1746-6148            Impact factor:   2.741


  21 in total

Review 1.  Tuberculosis-like pneumonias by the aerobic actinomycetes Rhodococcus, Tsukamurella and Gordonia.

Authors:  Vincenzo Savini; Paolo Fazii; Marco Favaro; Daniela Astolfi; Ennio Polilli; Arianna Pompilio; Mariangela Vannucci; Claudio D'Amario; Giovanni Di Bonaventura; Carla Fontana; Domenico D'Antonio
Journal:  Microbes Infect       Date:  2011-12-06       Impact factor: 2.700

2.  Virulence evolution in emerging infectious diseases.

Authors:  Jean-Baptiste André; Michael E Hochberg
Journal:  Evolution       Date:  2005-07       Impact factor: 3.694

3.  Spacer oligonucleotide typing of Mycobacterium bovis strains from cattle and other animals: a tool for studying epidemiology of tuberculosis.

Authors:  A Aranaz; E Liébana; A Mateos; L Dominguez; D Vidal; M Domingo; O Gonzolez; E F Rodriguez-Ferri; A E Bunschoten; J D Van Embden; D Cousins
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

4.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors:  J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

5.  Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.

Authors:  H Martin Vordermeier; Mark A Chambers; Paul J Cockle; Adam O Whelan; Jennifer Simmons; R Glyn Hewinson
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

6.  Assessment of in vivo and in vitro tuberculosis diagnostic tests in Mycobacterium caprae naturally infected caprine flocks.

Authors:  Javier Bezos; Julio Alvarez; Lucía de Juan; Beatriz Romero; Sabrina Rodríguez; Isabel G Fernández-de-Mera; R Glyn Hewinson; Martin Vordermeier; Ana Mateos; Lucas Domínguez; Alicia Aranaz
Journal:  Prev Vet Med       Date:  2011-05-04       Impact factor: 2.670

7.  Assessment of genetic markers for species differentiation within the Mycobacterium tuberculosis complex.

Authors:  E Liébana; A Aranaz; B Francis; D Cousins
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

8.  Mycobacterium bovis with different genotypes and from different hosts induce dissimilar immunopathological lesions in a mouse model of tuberculosis.

Authors:  D Aguilar León; M J Zumárraga; R Jiménez Oropeza; A K Gioffré; A Bernardelli; H Orozco Estévez; A A Cataldi; R Hernández Pando
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

9.  Bovine tuberculosis (Mycobacterium bovis) in wildlife in Spain.

Authors:  Alicia Aranaz; Lucía De Juan; Natalia Montero; Celia Sánchez; Margarita Galka; Consuelo Delso; Julio Alvarez; Beatriz Romero; Javier Bezos; Ana I Vela; Victor Briones; Ana Mateos; Lucas Domínguez
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

10.  Risk factors associated with the prevalence of tuberculosis-like lesions in fenced wild boar and red deer in south central Spain.

Authors:  Joaquín Vicente; Ursula Höfle; Joseba M Garrido; Isabel G Fernández-de-Mera; Pelayo Acevedo; Ramón Juste; Marta Barral; Christian Gortazar
Journal:  Vet Res       Date:  2007-04-11       Impact factor: 3.683

View more
  1 in total

1.  Single Nucleotide Polymorphisms in the Bovine TLR2 Extracellular Domain Contribute to Breed and Species-Specific Innate Immune Functionality.

Authors:  Marie-Christine Bartens; Amanda J Gibson; Graham J Etherington; Federica Di Palma; Angela Holder; Dirk Werling; Sam Willcocks
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.